2 Stories

New Class of Drugs Could Revolutionize Cancer Treatment

PARP inhibitors show potential to transform understanding of cancer

(Newser) - A new class of drugs in development represents the biggest cancer breakthrough in a decade, Robert Bazell writes at NBC. In a study causing much excitement in the medical world, breast, ovarian, and prostate cancer patients treated with Olaparib, one of a group of drugs known as PARP inhibitors, had... More »

Drug Offers Hope for Genetic Breast Cancer Sufferers

First-of-its-kind drug slows, stops tumor growth

(Newser) - A first-of-its-kind drug has been developed to fight genetic breast cancer, with an initial round of human trials showing “very promising” results, reports the Times of London. The drug Olaparib works by blocking a protein that makes cancer cells containing the genetic default unable to repair themselves. The drug... More »

2 Stories